| Report ID |
67310 |
| Drug Identification Number |
02230737 |
| Brand name |
LOSEC 10 MG |
| Common or Proper name |
omeprazole magnesium delayed release tablets |
| Company Name |
ASTRAZENECA CANADA INC |
| Market Status |
CANCELLED POST MARKET |
| Active Ingredient(s) |
OMEPRAZOLE |
| Strength(s) |
10MG |
| Dosage form(s) |
TABLET (DELAYED-RELEASE) |
| Route of administration |
ORAL |
| Packaging size |
2 x 15 |
| ATC code |
A02BC |
| ATC description |
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage |
Other (Please describe in comments) |
| Anticipated start date |
2018-12-14 |
| Actual start date |
2018-12-14 |
| Estimated end date |
Unknown |
| Actual end date |
|
| Shortage status |
Actual shortage |
| Updated date |
2019-11-18 |
| Company comments |
The product will be discontinued as of November 16, 2019. |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
